ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Retail Trade

Sundrug Co., Ltd.

Business Summary

Sundrug Co., Ltd. engages in the pharmaceutical business. It operates through the Drug Store and Discount Store segments. The Drug Store segment sells pharmaceutical products, cosmetics, and general merchandise. The Discount Store segment offers household goods and food products. The company was founded by Yukimasa Tada in December 1957 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2022 JPYUSD
Revenue648,734M5,773.05M
Gross Profit156,506M1,392.74M
Operating income34,052M303.02M
Income before tax34,675M308.57M
Net income23,853M212.26M
EBITDA44,261M393.87M
Diluted EPS204.001.81
Dividends Per Share710.63
Total Assets325,768M2,683.97M
Total liabilities105,174M866.52M
Total equity220,592M1,817.44M
Operating cash flow31,682M281.93M
Currency in JPYCurrency in USD

Historical Data

 Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Revenue 564,215M 588,069M 617,769M 634,310M 648,734M
Gross Profit 140,959M 147,178M 154,619M 158,550M 156,506M
Operating income 36,081M 35,234M 36,606M 37,346M 34,052M
Income before tax 36,598M 35,071M 34,648M 37,188M 34,675M
Net income 24,829M 23,933M 23,692M 25,329M 23,853M
EBITDA 43,869M 43,476M 44,965M 46,009M 44,261M
Diluted EPS 212.30 204.75 202.66 216.63 204.00
Dividends Per Share 60 66 68 70 71
Total Assets 246,619M 262,195M 284,276M 308,528M 325,768M
Total liabilities 91,789M 91,137M 97,452M 103,369M 105,174M
Total equity 154,828M 171,055M 186,822M 205,156M 220,592M
Operating cash flow 36,148M 31,091M 32,274M 31,761M 31,682M
 Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Revenue 5,090.70M 5,302.95M 5,681.90M 5,980.81M 5,773.05M
Gross Profit 1,271.82M 1,327.18M 1,422.10M 1,494.94M 1,392.74M
Operating income 325.54M 317.72M 336.68M 352.13M 303.02M
Income before tax 330.21M 316.25M 318.67M 350.64M 308.57M
Net income 224.02M 215.81M 217.90M 238.82M 212.26M
EBITDA 395.81M 392.04M 413.56M 433.81M 393.87M
Diluted EPS 1.91 1.84 1.86 2.04 1.81
Dividends Per Share 0.54 0.59 0.62 0.66 0.63
Total Assets 2,318.93M 2,368.83M 2,633.28M 2,792.10M 2,683.97M
Total liabilities 863.08M 823.39M 902.70M 935.46M 866.52M
Total equity 1,455.83M 1,545.42M 1,730.55M 1,856.61M 1,817.44M
Operating cash flow 326.15M 280.36M 296.83M 299.46M 281.93M

Valuation Measures

Mar 2022
PER14.58
ROA7.52%
ROE11.20%
Operating margin5.24%
Profit margin3.67%

Key executives

  • President & Representative Director: Hiroshi Sadakata
  • Director & General Manager-Administration: Naoki Tada
  • Manager-Administration: Yoshinobu Kato

Shareholders

  • TADA NAOKI /SUNDRUG/ (39.2%)
  • Fidelity Management & Research Co. LLC (2.4%)
  • Nomura Asset Management Co., Ltd. (2.3%)
  • Sundrug Co., Ltd. (2.0%)
  • TADA TAKASHI (1.8%)
  • Templeton Global Advisors Ltd. (1.5%)
  • The Vanguard Group, Inc. (1.4%)
  • Mawer Investment Management Ltd. (1.2%)
  • Massachusetts Financial Services Co. (1.0%)
  • Mondrian Investment Partners Ltd. (1.0%)

Contact Details

Related Companies

  • PiuMagi Co., Ltd.
  • Sundrug Plus KK
  • Sundrug Tokai KK
  • Sun Drug Pharmacies KK
  • Seikoudo Yakkyoku KK
  • DIREX Corp.
  • Act KK

Competitors

  • Welcia Holdings Co., Ltd.
Last Updated on 4 Oct, 2022

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more